
New index reveals Eli Lilly as the top ranked company
Norstella has announced the launch of the Pipeline-to-Patient Productivity Index (P3i), a new annual benchmark measuring R&D productivity, market access, and commercial return across the top 25 global biopharma companies. The P3i is the first benchmark to follow drug performance across the entire development and commercialisation lifecycle. The index is… Read More



